SUI:NYSESun Communities, Inc. Analysis
Data as of 2026-05-03 - not real-time
$126.55
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
The stock is trading near its short‑term moving average, with the medium‑term average just above current levels, suggesting a neutral near‑term bias. The relative strength index sits in the middle of its range, indicating neither overbought nor oversold conditions. The MACD histogram remains negative, pointing to lingering bearish momentum. Volume has been picking up, supporting the price action. 30‑day price swings are moderate and the beta is low, meaning the stock moves less than the broader market. Investor sentiment is in the extreme greed zone, reflecting strong market enthusiasm.
Fundamentally, the company posted solid revenue growth and maintains healthy gross and operating margins, while its funds‑from‑operations per share showed a notable rise. However, the trailing earnings per share is still negative and the forward earnings multiple is well above the industry average, indicating valuation pressure. The dividend yield is attractive but the payout ratio is well over 100%, raising concerns about sustainability. Leverage is high relative to equity, and the discounted cash‑flow model suggests a fair value far below the current market price, implying the stock is overvalued. Analyst consensus remains a buy with target prices that sit below today’s level, and recent news highlighted strong FFO growth, a strategic acquisition in the United Kingdom, and an upcoming earnings release that reported a net loss but a healthy FFO per share. Given these mixed signals, investors should be cautious.
Fundamentally, the company posted solid revenue growth and maintains healthy gross and operating margins, while its funds‑from‑operations per share showed a notable rise. However, the trailing earnings per share is still negative and the forward earnings multiple is well above the industry average, indicating valuation pressure. The dividend yield is attractive but the payout ratio is well over 100%, raising concerns about sustainability. Leverage is high relative to equity, and the discounted cash‑flow model suggests a fair value far below the current market price, implying the stock is overvalued. Analyst consensus remains a buy with target prices that sit below today’s level, and recent news highlighted strong FFO growth, a strategic acquisition in the United Kingdom, and an upcoming earnings release that reported a net loss but a healthy FFO per share. Given these mixed signals, investors should be cautious.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price near short‑term moving average
- bearish MACD momentum
- upcoming earnings release with mixed results
Medium Term
1–3 yearsCautious
Model confidence: 7/10
Key Factors
- valuation well above discounted cash‑flow estimate
- unsustainable dividend payout ratio
- high leverage relative to equity
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- diversified portfolio across North America and the United Kingdom
- steady FFO growth and attractive dividend yield
- potential for price correction toward fair value
Key Metrics & Analysis
Financial Health
Revenue Growth8.60%
Profit Margin59.65%
P/E Ratio45.3
ROE0.25%
ROA2.18%
Debt/Equity62.53
P/B Ratio2.2
Op. Cash Flow$902.3M
Free Cash Flow$524.0M
Industry P/E33.8
Technical Analysis
TrendNeutral
RSI42.2
Support$125.04
Resistance$131.18
MA 20$128.60
MA 50$130.85
MA 200$127.08
MACDBearish
VolumeIncreasing
Fear & Greed Index91.09
Valuation
Fair Value$49.05
Target Price$143.06
Upside/Downside13.04%
GradeOvervalued
TypeBlend
Dividend Yield3.35%
Risk Assessment
Beta0.25
Volatility15.48%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.